Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,376-1,400 of 2,022
Not Yet RecruitingNCT06904092

Efficacy and Mechanisms of TUS on Cognitive Deficits in Schizophrenia: Based on the Hippocampal-Prefrontal Circuit

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
TerminatedNCT05957484

The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Active Not RecruitingNCT06278246

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

This study exists to learn from real-world information that can show how smoking support or smoking-related treatment fits into care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT04033679

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT06107803

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
RecruitingNCT05783063

iTBS for Increased Appetite Induced by Antipsychotics

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
CompletedNCT06895421

Culturally Adapted Cognitive Behavior Therapy Based Guided Self-help Manual for Schizophrenia Spectrum Disorder

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Pakistan
Sponsor
University of the Punjab
Condition
Schizophrenia
RecruitingNCT05985993

Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT06728241

Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 17 Years to 65 Years
Countries
Norway
Sponsor
Oslo University Hospital
Condition
Schizophrenia
RecruitingNCT04278339

Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder

This study exists to explore whether the medication Electrophysiological could improve care and understanding. Researchers are trying to understand whether the medication Electrophysiological can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Schizophrenia
CompletedNCT03245437

Target Engagement and Response to Oxytocin

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT03983018

Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

This study exists to explore whether the medication PS-2019 could improve care and understanding. Researchers are trying to understand what the medication PS-2019 can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Sweden
Sponsor
Region Örebro County
Condition
Schizophrenia
WithdrawnNCT00916201

Evaluation Study of New Compounds With Potential Use in Schizophrenia

This study exists to explore whether the medication New could improve care and understanding. Researchers are trying to understand what the medication New could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
RecruitingNCT06886945

An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders

This study exists to improve how a digital app or remote support tool can help identify, measure, or follow care over time. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Italy
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Condition
Schizophrenia
TerminatedNCT05359081

A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Japan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
RecruitingNCT06882538

The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Turkey
Sponsor
Kastamonu University
Condition
Schizophrenia
Active Not RecruitingNCT05813080

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 40 Years
Countries
Germany
Sponsor
Heinrich-Heine University, Duesseldorf
Condition
Schizophrenia
RecruitingNCT04871048

Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia

This study exists to understand what helps smoking support or smoking-related treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
CompletedNCT06880328

18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
CompletedNCT02237417

Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Utah
Condition
Schizophrenia
RecruitingNCT04655235

Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
Germany
Sponsor
RWTH Aachen University
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research